These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16393993)

  • 1. Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation.
    Chapiro J; Claverol S; Piette F; Ma W; Stroobant V; Guillaume B; Gairin JE; Morel S; Burlet-Schiltz O; Monsarrat B; Boon T; Van den Eynde BJ
    J Immunol; 2006 Jan; 176(2):1053-61. PubMed ID: 16393993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the processing of seven human tumor antigens by intermediate proteasomes.
    Guillaume B; Stroobant V; Bousquet-Dubouch MP; Colau D; Chapiro J; Parmentier N; Dalet A; Van den Eynde BJ
    J Immunol; 2012 Oct; 189(7):3538-47. PubMed ID: 22925930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.
    Dalet A; Stroobant V; Vigneron N; Van den Eynde BJ
    Eur J Immunol; 2011 Jan; 41(1):39-46. PubMed ID: 21182075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.
    Ma W; Vigneron N; Chapiro J; Stroobant V; Germeau C; Boon T; Coulie PG; Van den Eynde BJ
    Int J Cancer; 2011 Nov; 129(10):2427-34. PubMed ID: 21207413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome.
    Schultz ES; Chapiro J; Lurquin C; Claverol S; Burlet-Schiltz O; Warnier G; Russo V; Morel S; Lévy F; Boon T; Van den Eynde BJ; van der Bruggen P
    J Exp Med; 2002 Feb; 195(4):391-9. PubMed ID: 11854353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
    Kierstead LS; Ranieri E; Olson W; Brusic V; Sidney J; Sette A; Kasamon YL; Slingluff CL; Kirkwood JM; Storkus WJ
    Br J Cancer; 2001 Nov; 85(11):1738-45. PubMed ID: 11742496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.
    Guillaume B; Chapiro J; Stroobant V; Colau D; Van Holle B; Parvizi G; Bousquet-Dubouch MP; Théate I; Parmentier N; Van den Eynde BJ
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18599-604. PubMed ID: 20937868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells.
    Chapatte L; Servis C; Valmori D; Burlet-Schiltz O; Dayer J; Monsarrat B; Romero P; Lévy F
    J Immunol; 2004 Nov; 173(10):6033-40. PubMed ID: 15528338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antigenic peptide produced by peptide splicing in the proteasome.
    Vigneron N; Stroobant V; Chapiro J; Ooms A; Degiovanni G; Morel S; van der Bruggen P; Boon T; Van den Eynde BJ
    Science; 2004 Apr; 304(5670):587-90. PubMed ID: 15001714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity.
    Vigneron N; Van den Eynde BJ
    Curr Opin Immunol; 2012 Feb; 24(1):84-91. PubMed ID: 22206698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL.
    Yang S; Linette GP; Longerich S; Roberts BL; Haluska FG
    Cell Immunol; 2000 Aug; 204(1):29-37. PubMed ID: 11006015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.
    Ma W; Zhang Y; Vigneron N; Stroobant V; Thielemans K; van der Bruggen P; Van den Eynde BJ
    J Immunol; 2016 Feb; 196(4):1711-20. PubMed ID: 26792804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.
    Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P
    J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors.
    Ito M; Koido S; Iwamoto T; Morimoto S; Fujiki F; Sugiyama H; Matsumoto S; Effenberger C; Kiyotani K; Shiba K
    PLoS One; 2024; 19(8):e0308330. PubMed ID: 39116074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell biology. Cutting and pasting antigenic peptides.
    Cresswell P
    Science; 2004 Apr; 304(5670):525-7. PubMed ID: 15105483
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
    J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome.
    Begley GS; Horvath AR; Taylor JC; Higgins CF
    Mol Immunol; 2005 Jan; 42(1):137-41. PubMed ID: 15488952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
    Mo AX; van Lelyveld SF; Craiu A; Rock KL
    J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5.
    Dalet A; Vigneron N; Stroobant V; Hanada K; Van den Eynde BJ
    J Immunol; 2010 Mar; 184(6):3016-24. PubMed ID: 20154207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
    Skipper JC; Kittlesen DJ; Hendrickson RC; Deacon DD; Harthun NL; Wagner SN; Hunt DF; Engelhard VH; Slingluff CL
    J Immunol; 1996 Dec; 157(11):5027-33. PubMed ID: 8943411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.